Glucodynamics and glucocracy in type 2 diabetes mellitus: clinical evidence and practice-based opinion on modern sulfonylurea use, from an international expert group (South Asia, Middle East & Africa) via modified Delphi method.

Glucodynamics and glucocracy in type 2 diabetes mellitus: clinical evidence and practice-based opinion on modern sulfonylurea use, from an international expert group (South Asia, Middle East & Africa) via modified Delphi method. Curr Med Res Opin. 2020 Dec 15;:1 Authors: Kalra S, Ak D, Md F, K S, P S, Aa R, M J, S S, A O, Mr S, Selim S, Mp B, Gangopadhyay KK, Ya L, T N, D D, Sd T, V D, Dutta D, H K, R M, S D, A D, A B, G P, S C, Dhingra A, N P, A AA, M M Abstract Type 2 diabetes mellitus (T2DM) is a global epidemic. According to international guidelines, the management protocol of T2DM includes lowering of blood glucose, along with preventing disease-related complications and maintaining optimal quality of life. Further, the guidelines recommend the use of a patient-centric approaches for the management of T2DM; however, Asian population is underrepresented in landmark cardiovascular outcome trials (CVOTs). There are several guidelines available today for the diagnosis and management of T2DM, and hence there is much confusion among practitioners about which guidelines to follow. A group of thirty international clinical experts comprising of endocrinologists, diabetologists and cardiologist from South Asia, Middle East and Africa met at New Delhi, India on February 8 and 9, 2020 and developed an international expert opinion statements via a structured modified Delphi method on the glucodynamic properties of OADs and the glucocrati...
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research